000 01654 a2200457 4500
005 20250517223551.0
264 0 _c20191114
008 201911s 0 0 eng d
022 _a2045-7634
024 7 _a10.1002/cam4.1631
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSarkar, Siddik
245 0 0 _aA novel chemotherapeutic protocol for peritoneal metastasis and inhibition of relapse in drug resistant ovarian cancer.
_h[electronic resource]
260 _bCancer medicine
_c08 2018
300 _a3630-3641 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCell Line, Tumor
650 0 4 _aDisease Models, Animal
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIrinotecan
_xadministration & dosage
650 0 4 _aMice
650 0 4 _aNeoplastic Stem Cells
_xmetabolism
650 0 4 _aOligopeptides
_xadministration & dosage
650 0 4 _aOvarian Neoplasms
_xpathology
650 0 4 _aPeritoneal Neoplasms
_xdrug therapy
650 0 4 _aSpheroids, Cellular
650 0 4 _aTreatment Outcome
650 0 4 _aTumor Cells, Cultured
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aMalekshah, Obeid M
700 1 _aNomani, Alireza
700 1 _aPatel, Niket
700 1 _aHatefi, Arash
773 0 _tCancer medicine
_gvol. 7
_gno. 8
_gp. 3630-3641
856 4 0 _uhttps://doi.org/10.1002/cam4.1631
_zAvailable from publisher's website
999 _c28553732
_d28553732